Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Coffman

Showing results (271-280 of 285) with videos related to

Pageof 29
Sort By:
Health Services Research|August 13, 2024
A stepped wedge cluster randomized trial to evaluate the effectiveness of a multisite family caregiver skills training programCourtney Harold Van Houtven, Cynthia J Coffman, Kasey Decosimo, et al.
Journal of General Internal Medicine|November 4, 2025
Implementing Advanced Comprehensive Diabetes Care Within the Veterans Affairs Learning Health SystemMatthew J Crowley, Sarah L Cutrona, Amy S Jeffreys, et al.
ACS Medicinal Chemistry Letters|June 17, 2026
Structure-Guided Discovery of Selective Polo-Like Kinase 3 InhibitorsJeremy L Yap, Gabrielle Lovett, Jeremy W Mason, et al.
Journal of General Internal Medicine|January 4, 2022
Implementation of an Intensive Telehealth Intervention for Rural Patients with Clinic-Refractory DiabetesElizabeth A Kobe, Allison A Lewinski, Amy S Jeffreys, et al.
Bioorganic & Medicinal Chemistry Letters|January 29, 2011
Design, synthesis, and in vivo characterization of a novel series of tetralin amino imidazoles as γ-secretase inhibitors: discovery of PF-3084014Michael A Brodney, David D Auperin, Stacey L Becker, et al.
Contemporary Clinical Trials|September 24, 2020
Practical telehealth to improve control and engagement for patients with clinic-refractory diabetes mellitus (PRACTICE-DM): Protocol and baseline data for a randomized trialElizabeth A Kobe, David Edelman, Phillip E Tarkington, et al.
Bioorganic & Medicinal Chemistry Letters|January 29, 2011
Diamide amino-imidazoles: a novel series of γ-secretase inhibitors for the treatment of Alzheimer's diseaseMichael A Brodney, David D Auperin, Stacey L Becker, et al.
Journal of Medicinal Chemistry|January 8, 2014
Discovery and preclinical characterization of 1-methyl-3-(4-methylpyridin-3-yl)-6-(pyridin-2-ylmethoxy)-1H-pyrazolo-[3,4-b]pyrazine (PF470): a highly potent, selective, and efficacious metabotropic glutamate receptor 5 (mGluR5) negative allosteric modulatorLei Zhang, Gayatri Balan, Gabriela Barreiro, et al.
Journal of Medicinal Chemistry|November 19, 2024
Discovery of First Branched-Chain Ketoacid Dehydrogenase Kinase (BDK) Inhibitor Clinical Candidate PF-07328948Kevin J Filipski, Luis A Martinez-Alsina, Matthew R Reese, et al.
Journal of Medicinal Chemistry|March 16, 2026
Discovery of Potent and Brain-Penetrant Inverse Agonists for GPR61, an Orphan G Protein-Coupled ReceptorEthan L Fisher, Anne-Marie Dechert Schmitt, Jamison B Tuttle, et al.
Pageof 29

Showing results (271-280 of 285) with videos related to

Sort By:
Pageof 29
Health Services Research|August 13, 2024
A stepped wedge cluster randomized trial to evaluate the effectiveness of a multisite family caregiver skills training programCourtney Harold Van Houtven, Cynthia J Coffman, Kasey Decosimo, et al.
Journal of General Internal Medicine|November 4, 2025
Implementing Advanced Comprehensive Diabetes Care Within the Veterans Affairs Learning Health SystemMatthew J Crowley, Sarah L Cutrona, Amy S Jeffreys, et al.
ACS Medicinal Chemistry Letters|June 17, 2026
Structure-Guided Discovery of Selective Polo-Like Kinase 3 InhibitorsJeremy L Yap, Gabrielle Lovett, Jeremy W Mason, et al.
Journal of General Internal Medicine|January 4, 2022
Implementation of an Intensive Telehealth Intervention for Rural Patients with Clinic-Refractory DiabetesElizabeth A Kobe, Allison A Lewinski, Amy S Jeffreys, et al.
Bioorganic & Medicinal Chemistry Letters|January 29, 2011
Design, synthesis, and in vivo characterization of a novel series of tetralin amino imidazoles as γ-secretase inhibitors: discovery of PF-3084014Michael A Brodney, David D Auperin, Stacey L Becker, et al.
Contemporary Clinical Trials|September 24, 2020
Practical telehealth to improve control and engagement for patients with clinic-refractory diabetes mellitus (PRACTICE-DM): Protocol and baseline data for a randomized trialElizabeth A Kobe, David Edelman, Phillip E Tarkington, et al.
Bioorganic & Medicinal Chemistry Letters|January 29, 2011
Diamide amino-imidazoles: a novel series of γ-secretase inhibitors for the treatment of Alzheimer's diseaseMichael A Brodney, David D Auperin, Stacey L Becker, et al.
Journal of Medicinal Chemistry|January 8, 2014
Discovery and preclinical characterization of 1-methyl-3-(4-methylpyridin-3-yl)-6-(pyridin-2-ylmethoxy)-1H-pyrazolo-[3,4-b]pyrazine (PF470): a highly potent, selective, and efficacious metabotropic glutamate receptor 5 (mGluR5) negative allosteric modulatorLei Zhang, Gayatri Balan, Gabriela Barreiro, et al.
Journal of Medicinal Chemistry|November 19, 2024
Discovery of First Branched-Chain Ketoacid Dehydrogenase Kinase (BDK) Inhibitor Clinical Candidate PF-07328948Kevin J Filipski, Luis A Martinez-Alsina, Matthew R Reese, et al.
Journal of Medicinal Chemistry|March 16, 2026
Discovery of Potent and Brain-Penetrant Inverse Agonists for GPR61, an Orphan G Protein-Coupled ReceptorEthan L Fisher, Anne-Marie Dechert Schmitt, Jamison B Tuttle, et al.
Pageof 29